November 13, 2018
Carol Conrad, MD, is the Medical Director of the Pediatric Lung and Heart-Lung Transplant Program, and Associate Professor of Pediatrics at Stanford University. While the number of children with cystic fibrosis requiring a double lung transplant are declining due to new therapies, each year, several children experience advanced end-stage lung disease requiring transplant. In this presentation, Dr. Conrad shares the history of pediatric transplant, the challenges and outcomes, and the future of transplant.
Filmed by Brandon Delgado and Alana Ocampo.
CF Community Voices is sponsored by Vertex Pharmaceuticals, Gilead Sciences and Chiesi USA.
November 13, 2018
Carol Conrad, MD, is the Medical Director of the Pediatric Lung and Heart-Lung Transplant Program, and Associate Professor of Pediatrics at Stanford University. While the number of children with cystic fibrosis requiring a double lung transplant are declining due to new therapies, each year, several children experience advanced end-stage lung disease requiring transplant. In this presentation, Dr. Conrad shares the history of pediatric transplant, the challenges and outcomes, and the future of transplant.
Filmed by Brandon Delgado and Alana Ocampo.
CF Community Voices is sponsored by Vertex Pharmaceuticals, Gilead Sciences and Chiesi USA.
October 30, 2018
Amy Rad teaches Pound Fitness, an exercise class which integrates the use of drumsticks and high-energy music to encourage a fun and effective workout. Amy's class is part of CFRI's Breathe In ~ Work Out CF Wellness Initiative, a series of online classes that promote physical wellness and community connection with others impacted by CF.
Filmed by Brandon Delgado and Alana Ocampo.
CF Community Voices is funded by grants from Vertex Pharmaceuticals, Chiesi USA and Gilead Sciences
October 30, 2018
Amy Rad teaches Pound Fitness, an exercise class which integrates the use of drumsticks and high energy music to encourage a fun and effective workout. Amy's class is part of CFRI's Breathe In ~ Work Out CF Wellness Initiative, a series of online classes that promote physical wellness and community connection with others impacted by CF.
Filmed by Brandon Delgado and Alana Ocampo.
CF Community Voices is funded by grants from Vertex Pharmaceuticals, Chiesi USA and Gilead Sciences
CFRI's Breathe In ~ Work Out CF Wellness Initiative is funded through a Circle of Care grant from Vertex Pharmaceuticals.
August 29, 2018
Manu Jain, MD, Reid D'Amico, PhD, Richard Moss, MD, Chelsea Toth, DSW, and Elaine Chen, MD, all conference presenters at CFRI's 31st National CF Family Education Conference, participate on a panel to answer questions from conference attendees.
This presentation was made on August 5, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
August 29, 2018
Dr. Rupal Shah and Dr. Jasleen Kukreja, both of UC San Francisco, provide a fascinating presentation reviewing the transplantation process, from the initial evaluation to post-transplant outcomes, for recipients with cystic fibrosis, and providing a fascinating overview of the newest innovations in lung transplant care for patients with cystic fibrosis.
This presentation was made on August 4, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
August 29, 2018
Cystic fibrosis was once pegged as a childhood disease but now has transitioned into a disease where people are living beyond childhood and into adulthood. Sabrina discusses strategies for coping with the unpredictable challenges that arise when living with cystic fibrosis. While staying adherent with medications and airway clearance is essential, Sabrina touches upon exercise as a complementary way to maintain health among those with CF. People with CF are now facing new life challenges like planning for the future in terms of careers, marriage, children and college. As an adult who is married and has a three-year-old son, Leo, Sabrina provides her personal perspective on having children with CF.
This presentation was made on August 5, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
August 29, 2018
Fungal infection in cystic fibrosis is a recognized challenge. In his presentation, Dr. Moss outlines our current understanding of the prevalence and diversity of fungal presence in the CF respiratory tract, and risk factors for acquiring fungi. He also addresses some of the body’s responses, advances in the diagnostic approaches to isolating and identifying fungi in CF respiratory samples,, and the challenges of classifying clinical presentations and problems (“phenotypes”) of CF patients harboring fungi, as well as current treatment approaches.
This presentation was made on August 5, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
August 29, 2018
As a member of the cystic fibrosis (CF) community, Reid discusses his personal experience as an adult with CF, along with his professional experiences as a biomedical engineer, advocate, and incoming scholar at the US Food and Drug Administration. Reid speaks about how CF can be used as a foundation for advancing insight in the fields of engineering and science. In particular, Reid shares how being an adult with CF allows him to experience the world differently, and ultimately influences his ability to innovate and create policy. Key objectives of Reid’s talk include: providing an overview of the psychological and physical challenges that may face members of the CF community in the lab or workplace; using a CF identity to challenge the status quo; discussing how the CF community can teach others to be agents of change in their personal and professional lives.
This presentation was made on August 3, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
August 29, 2018
Life expectancy in cystic fibrosis (CF) has improved substantially over the last 75 years, with a median predicted survival of approximately 47 years. This has been due for the most part to therapies that have targeted lung disease and other end organ manifestations in an attempt to disrupt the cycle of mucous obstruction, inflammation, and infection. In his fascinating overview of the CF therapeutic pipeline, Dr. Jain discusses CFTR modulators, RNA editing, novel anti-inflammatory drugs, antibiotics and advances in lung transplantation.
This presentation was made on August 4, 2018, at CFRI's 31st National Cystic Fibrosis Family Education Conference.
Conference sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and the Boomer Esiason Foundation.
